The groundbreaking approach of the medication represents a significant development in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment